IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI) today announced the appointment of Richard A. Bender, MD, FACP to the position of Senior Vice President and Chief Medical Officer. Reporting to Gino Lenaz, MD, Chief Scientific Officer, Dr Bender will be responsible for strategic planning and implementation of the company’s clinical programs.
